What is the market cap difference between AMGN and GILD?

AMGN has a market cap of $188.6B and GILD has a market cap of $172.6B. AMGN has a 1.1x larger market capitalization than GILD

AMGN vs GILD Stock Comparison

Compare Amgen Inc. (AMGN) and Gilead Sciences, Inc. (GILD) side by side. View price, valuation, dividends, and financial metrics.

Amgen Inc.

$349.67-0.04%

Healthcare / Drug Manufacturers - General · $188.6B market cap

Gilead Sciences, Inc.

$138.58-0.32%

Healthcare / Drug Manufacturers - General · $172.6B market cap

Both AMGN and GILD operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

AMGN has a 1.1x larger market capitalization than GILD.

GILD trades at a lower P/E ratio (20.5x) compared to AMGN (24.6x), suggesting GILD may be more attractively valued relative to its earnings.

AMGN offers a higher dividend yield (2.88%) vs GILD (2.36%), making it more attractive for income investors.

Looking at profitability, AMGN has a profit margin of 21.0% while GILD's is 28.9%. GILD converts more of its revenue into profit.

In terms of growth, AMGN has revenue growth of 8.6% versus 4.7% for GILD. AMGN is growing its top line faster.

Which is a better investment, AMGN or GILD?: Both stocks have different strengths. Amgen Inc. (AMGN) trades at $349.67 with a $188.6B market cap, while Gilead Sciences, Inc. (GILD) trades at $138.58 with a $172.6B market cap. GILD trades at a lower P/E ratio (20.5x) compared to AMGN (24.6x), suggesting GILD may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are AMGN and GILD in the same sector?: Both AMGN and GILD operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do AMGN and GILD pay dividends?: AMGN offers a higher dividend yield (2.88%) vs GILD (2.36%), making it more attractive for income investors.